- Home
- NGNE vs ABSI Comparison
NGNE vs ABSI Comparison
Compare NGNE & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGNE
- ABSI
- Stock Information
- Founded
- NGNE 2003
- ABSI 2011
- Country
- NGNE United States
- ABSI United States
- Employees
- NGNE N/A
- ABSI N/A
- Industry
- NGNE Biotechnology: Pharmaceutical Preparations
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- NGNE Health Care
- ABSI Health Care
- Exchange
- NGNE Nasdaq
- ABSI Nasdaq
- Market Cap
- NGNE 471.1M
- ABSI 457.6M
- IPO Year
- NGNE N/A
- ABSI 2021
- Fundamental
- Price
- NGNE $15.59
- ABSI $2.55
- Analyst Decision
- NGNE Strong Buy
- ABSI Strong Buy
- Analyst Count
- NGNE 6
- ABSI 6
- Target Price
- NGNE $60.80
- ABSI $8.67
- AVG Volume (30 Days)
- NGNE 539.5K
- ABSI 1.5M
- Earning Date
- NGNE 11-18-2024
- ABSI 11-12-2024
- Dividend Yield
- NGNE N/A
- ABSI N/A
- EPS Growth
- NGNE N/A
- ABSI N/A
- EPS
- NGNE N/A
- ABSI N/A
- Revenue
- NGNE $925,000.00
- ABSI $4,207,000.00
- Revenue This Year
- NGNE N/A
- ABSI $9.36
- Revenue Next Year
- NGNE N/A
- ABSI $198.59
- P/E Ratio
- NGNE N/A
- ABSI N/A
- Revenue Growth
- NGNE N/A
- ABSI N/A
- 52 Week Low
- NGNE $12.49
- ABSI $1.35
- 52 Week High
- NGNE $74.49
- ABSI $6.72
- Technical
- Relative Strength Index (RSI)
- NGNE 26.51
- ABSI 24.46
- Support Level
- NGNE $35.60
- ABSI $2.45
- Resistance Level
- NGNE $43.24
- ABSI $4.47
- Average True Range (ATR)
- NGNE 6.30
- ABSI 0.28
- MACD
- NGNE -5.15
- ABSI -0.15
- Stochastic Oscillator
- NGNE 1.85
- ABSI 4.96
About NGNE Neurogene Inc.
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.